DEA Required Course

ONE-TIME 8-HOUR TRAINING FOR ALL DEA REGISTERED PRACTITIONERS

The Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) released materials in March 2023 related to the new Medication Access and Training Expansion (MATE) Act. The Act requires new or renewing DEA licensees (excluding veterinarians), as of June 27, 2023, to have completed a total of at least eight hours of training on opioid or other substance use disorders and the appropriate treatment of pain.

FOMA Members may can take the course complimentary ($99 for non-members) by calling the FOMA for the discount code at (800) 226-3662 or emailing admin@foma.org.

The FOMA 6-hour DEA course includes topics on opioid & substance use disorders and may fulfill a portion of the new DEA MANDATED 8-hour training on the treatment and management of patients with opioid or other substance use disorders.

MEETING THE NEW DEA REQUIREMENT

The new DEA requirement is 8 hours. A provider needing all 8 hours may fulfill their responsibility by completing this 6-hour course, in addition to the Florida mandated 2-hour Prescribing Controlled Substances course.

ADDITIONAL INFORMATION
Read DEA Letter

Beginning June 27, 2023, you will be required to check a box on the registration form at renewal or initial registration, affirming the completion of the new training requirement.

While this is a new requirement for educational training, your past training CAN be counted toward this new requirement! If you have already taken courses on opioid or other use disorders, you can use those toward completing this new requirement. If you have already taken the 2-hour prescribing controlled substances, that will count toward the 8 total hours. What group are you in?
 
Practitioners are lumped into three groups, groups 1 & 2 are exempt, group 3 must complete or have completed in past training sessions.Group 1 – All practitioners that are board certified in addiction medicine or addiction psychiatry from the ABMS, ABAM or the AOA.

  1. Group 2 – All practitioners graduating from an osteopathic medical school within 5 years who completed a comprehensive curriculum that included at least 8 hours of training on treating and managing patients with opioid or other substance use disorders including the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of a substance use disorder; or Safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders.
  2. Group 3 – All other practitioners not in groups 1 or 2, must acknowledge completion of at least 8-hours of training on the treatment and management of patients with opioid or other substance use disorders from the groups listed below. Key points are:
  • The training does not have to occur in one session. It can be cumulative across multiple sessions that equal eight hours of training.
  • Past trainings on the treatment and management of patients with opioid or other substance use disorders can count towards a practitioner meeting this requirement. In other words, if you received a relevant training from one of the groups listed below—prior to the enactment of this new training obligation on December 29, 2022—that training counts towards the eight-hour requirement.
  • Past DATA-Waived trainings count towards a DEA registrant’s 8-hour training requirement.
  •  Trainings can occur in a variety of formats, including classroom settings, seminars at professional society meetings, or virtual offerings.

Approved providers:
 What accredited groups may provide trainings that meet this new requirement?

  • The American Society of Addiction Medicine (ASAM)
  • The American Academy of Addiction Psychiatry (AAAP)
  • American Medical Association (AMA)
  • The American Osteopathic Association (AOA), or any organizations accredited by the AOA
  • to provide continuing medical education
  • The American Dental Association (ADA)
  • The American Association of Oral and Maxillofacial Surgeons (AAOMS)
  • The American Psychiatric Association (APA)
  • The American Association of Nurse Practitioners (AANP)
  • The American Academy of Physician Associates (AAPA)
  • The American Nurses Credentialing Center (ANCC)
  • Any other organization accredited by the Accreditation Council for Continuing Medical
  • Education (AACCME) or the Commission for Continuing Education Provider Recognition
  • (CCEPR), whether directly or through an organization accredited by a State medical society
  • that is recognized by the ACCME or CCEPR
  • Any other organization approved or accredited by the Assistant Secretary for Mental Health
  • and Substance Use, the ACCME, or the CCEPR

LEGAL DISCLAIMER

The information contained in this document is provided to you "AS IS", does not constitute legal advice, and is governed by our Terms and Conditions of Use. We make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in this article.

The FOMA, its employees, agents, or others that provide information on or through this will not be liable or responsible to you for any claim, loss, injury, liability, or damages related to your use of this article. You should always consult a health care attorney.